Lime Delivers Record Revenue and Profitability, Positive Free Cash Flow in 2024
18.2.2025 12:00:00 CET | Business Wire | Press release
Global Micromobility Leader’s Business Momentum Delivers Profitable GrowthGross Bookings of $810 Million, Net Revenue of $686 MillionAdjusted EBITDA Exceeds $140 Million, Up From $94 Million in 2023Free Cash Flow Positive for Second Consecutive Year
Lime, the world’s largest shared electric vehicle company, today announced record unaudited financial results for 2024, reflecting continued operating and financial momentum as the Company executes against its mission to build a future where transportation is shared, affordable and carbon-free.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250218624910/en/
Two young women ride Lime electric bikes through a city. (Photo: Business Wire)
Full Year 2024 Financial Highlights (unaudited)
- Gross bookings of $810 million, reflecting growth of 31% versus 2023
- Net revenue of $686 million, an increase of 32% compared to 2023
- Fourth consecutive year of 30%+ topline growth
- Adjusted EBITDA1 over $140 million, up from $94 million in 2023, representing year-over-year growth of 49%
- Adjusted EBITDA margin1 over 20%, representing more than 200 basis points of expansion versus prior year
- Free cash flow positive for second consecutive year
“2024 was an exceptional year for Lime and our global leadership is evident both operationally and financially with strong results across all of our key metrics,“ said Wayne Ting, CEO. “We grew profits faster than revenue in 2024, posting another record year of results through serving more than 24 million riders in hundreds of communities around the world and bringing Lime to more cities globally. As we continue to expand our fleet, our permit win and retention rates demonstrate that Lime remains the clear choice for cities seeking to reduce traffic congestion and meet carbon emission goals. While we saw record demand in 2024, we’re just scratching the surface of micromobility’s potential to transform cities and better connect people. Our proven execution, combined with these global tailwinds, position Lime for durable growth for years to come.”
Full Year 2024 Operating Highlights and Metrics
- Provided more than 200 million rides in 2024, up 30% from 2023, equating to more than six rides per second, with more than 24 million riders taking a trip in 2024
- Surpassed 750 million lifetime rides
- Won over 90% of competitive permits to operate in top tier cities
- Expanded to more than 20 new cities globally, including launches into two new countries, Japan and Greece
- Expanded average operational fleet by nearly 20% to over 270,000 vehicles globally
Lime also deepened its management team in 2024, with key executive appointments who draw on decades of experience at Fortune 500 companies. Chief Legal Officer Susie Giordano brings more than 30 years of experience in capital markets, governance, compliance and M&A, including serving as the Corporate Secretary for Intel Corporation. Incoming Chief Technology Officer Jon Jenkins joined Lime from Amazon, with prior roles including Head of Engineering at Pinterest.
“As we continue to advance our mission, we are driving consistent growth through fleet expansion, increased rider utilization, geographic expansion and continuous innovation,” said Ann Gugino, CFO. “We are well above a ‘rule of 40’ company and are intently focused on scaling our unit economics. In 2024, we invested for growth, while simultaneously delivering increased profitability and positive free cash flow. Importantly, our team has a proven track record of strong execution and Lime has an exciting roadmap and multiple avenues for growth in 2025 and beyond.”
Environmental sustainability remains a key focus for Lime and it continues to make an impact on reducing carbon emissions in cities. Last year, riders avoided an estimated 20,000 metric tons of CO2 emissions, spared an estimated 2.2 million gallons of gas (8.5M liters) from being consumed and replaced more than an estimated 43 million car trips with two-wheeled, emissions-free rides. Lime also continues to make meaningful strides in reducing its own carbon intensity across Scopes 1, 2 and 3 emissions. Its most recent carbon inventory measuring 2023 impact showed a 59.5% reduction from its 2019 baseline. Lime plans to release its 2024 carbon inventory later this spring.
About Lime
Lime’s mission is to build a future where transportation is shared, electric and carbon-free. As a leading global provider of shared electric vehicles, Lime partners with cities to deploy electric bikes and scooters to serve any trip under five miles. A Time Magazine 100 Most Influential Companies and Fast Company Brand that Matters, Lime has powered more than 750 million rides across five continents, spurring a new generation of clean alternatives to car ownership. Learn more at li.me.
_____________________
1 The company’s unaudited financial results communicated herein reflect certain non-GAAP financial measures. In particular, the Company presents adjusted EBITDA which is defined as earnings before interest, income taxes, depreciation and amortization, and excludes certain items that affect comparability from period to period or are not indicative of our ongoing operating performance, and Adjusted EBITDA margin, which is calculated as Adjusted EBITDA/Net Revenue. The non-GAAP financial measures provided in this press release are not a substitute for the company’s financial results prepared in accordance with U.S. GAAP and may be different from similarly-titled non-GAAP measures used by other companies. Unaudited financial results communicated herein are subject to change upon finalization of the audit.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250218624910/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release
The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom